Table 2 Stratified analysis of components of MetS syndrome measured in healthy volunteers, controlled and uncontrolled MetS subjects.
Healthy volunteers (n = 149) | Controlled MetS (n = 72) | Uncontrolled MetS (n = 77) | |||||||
|---|---|---|---|---|---|---|---|---|---|
Male/female | 74/75 | 36/36 | 41/36 | ||||||
Mean | Range | SD | Mean | Range | SD | Mean | Range | SD | |
T/S ratio | 0.95 | 0.32–1.54 | 0.3 | 0.93 | 0.48–1.54 | 0.3 | 0.92 | 0.53–1.54 | 0.2 |
Age (years) | 54.8 | 40–70 | 9.4 | 55.1 | 40–70 | 8.9 | 54.8 | 40–70 | 8.0 |
WC (cm) | 79.83 | 71–89 | 4.9 | 89.80 | 75–110 | 7.9 | 100.27 | 72–150 | 13.0 |
Triglycerides (mg/dL) | 132.64 | 109–150 | 6.9 | 162.47 | 110–270 | 10.9 | 209.51 | 122–378 | 43.7 |
HDL (mg/dL) | 47.15 | 30–57 | 5.8 | 46.33 | 30–57 | 6.5 | 38.72 | 15–64 | 14.8 |
SBP (mmHg) | 117.32 | 105–125 | 2.5 | 121.03 | 110–140 | 4.4 | 142.83 | 120–180 | 10.0 |
DBP (mmHg) | 72.38 | 70–75 | 10.4 | 78.21 | 70–90 | 36.3 | 89.42 | 75–120 | 60.8 |
FBS (mg/dL) | 89.81 | 74–99 | 6.7 | 106.63 | 88–130 | 7.0 | 171.34 | 110–300 | 7.7 |